Mexichem’s Fluor  Business Group is the leading manufacturer and supplier of HFA medical propellants. Around 80% of the world’s Metered Dose Inhalers (MDIs) are powered by Zephex® HFA propellants, helping to improve the lives of over 100 million people every year.

Mexichem’s detailed understanding of the needs, standards and regulatory requirements of our pharmaceutical customers combined with expertise in fluorine chemistry and chemical handling makes us unique in the manufacture of propellants for pharmaceutical uses.

Zephex®134a and Zephex®227ea are low boiling, non-toxic and non-flammable hydrofluoroalkane (HFA) propellant gases and both comply with the relevant industry toxicological specifications (IPACTl and ll).

Zephex® propellants are produced, tested and released from facilities dedicated to the production of pharmaceutical grades of HFA 134a and HFA 227ea. Zephex® products are made in accordance with current Good Manufacturing Practice (cGMP), as required by our customers, the US Food and Drug Administration and the UK Medicines and Healthcare Products Regulatory Agency.